Kelly K, Bloor AJC, Griffin JE, Radia R, et al. Two-year safety outcomes of iPS cell-derived mesenchymal stromal cells in acute steroid-resistant graft-versus-host disease. Nat Med 2024 May 22. doi: 10.1038/s41591-024-02990.
PMID: 38778211